Baseline serum matrix metalloproteinase-9 level predicts long-term prognosis after coronary revascularizations in stable coronary artery disease

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.

Zorina S. Galis, Galina K. Sukhova, Michael W. Lark et al. · Journal of Clinical Investigation · 1994 · 2.5K citations · Full text

COLLAGENOLYTIC ACTIVITY IN AMPHIBIAN TISSUES: A TISSUE CULTURE ASSAY

Jerome Gross, Charles M. Lapière · Proceedings of the National Academy of Sciences · 1962 · 1.3K citations · Full text

Plasma Concentrations and Genetic Variation of Matrix Metalloproteinase 9 and Prognosis of Patients With Cardiovascular Disease

Stefan Blankenberg, Hans J. Rupprecht, Odette Poirier et al. · Circulation · 2003 · 750 citations · Full text

Elevation of C-reactive protein in “active” coronary artery disease

Bradford C. Berk, William S. Weintraub, R. Wayne Alexander · The American Journal of Cardiology · 1990 · 592 citations

Inflammation, C-reactive Protein, Cardiovascular Disease +6

Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes

Hisashi Kai, Hisao Ikeda, Hideo Yasukawa et al. · Journal of the American College of Cardiology · 1998 · 591 citations

Inflammation, Thrombosis, Vascular Disease +14